Rivaroxaban and low-molecular-weight heparin can limit tumor metastasis in mice fibrosarcoma models (145), with rivaroxaban additionally amplifying cytotoxic T-cell responses and stimulating antigen-presenting cells by modulating the FXa-PAR2 axis (145). This evidence concerns the gene F10 and neoplasm.